Coherus Confident On Avastin This Year With Humira Goal Achieved

Filing Of Adalimumab Was Slated For Q4 2020

 
• By Dean Rudge
Light bulb
Coherus is aiming to file its partnered bevacizumab in the back half of this year. • Source: Shutterstock

More from Biosimilars

More from Products